Key result
MedEng-ST bicuspid mechanical prosthesis shows 0% prosthesis-associated complications and decreased aortic gradients.
Why the study?
New bicuspid full-flow mechanical prostheses have appeared on the market, prompting clinical follow-up to assess the performance of the MedEng-ST prosthesis in cardiac valve repair.
Does the bicuspid full-flow mechanical prosthesis 'MedEng-ST' provide stable haemodynamics and safety in patients undergoing cardiac valve repair?
Cohort (n=84)
No
Does the bicuspid full-flow mechanical prosthesis 'MedEng-ST' provide stable haemodynamics and safety in patients undergoing cardiac valve repair?
The 'MedEng-ST' bicuspid full-flow mechanical prosthesis demonstrated good haemodynamic performance and safety for aortic and mitral valve replacement in a retrospective cohort.
Hypothesis-generating for the MedEng-ST prosthesis; prospective trials needed before clinical adoption.
Prosthetic repair of cardiac valves with artificial mechanical prostheses is ubiquitously performed using prostheses consisting of two cusps (bicuspidal). Several years ago, new bicuspid full-flow prostheses appeared on the market. From the first use they immediately proved reliable, with stable haemodynamic characteristics. At the Interregional Clinical and Diagnostic Centre, bicuspid full-flow mechanical prostheses 'MedEng-ST' have been used since 2017. We carried out a retrospective follow up of 84 patients subjected to prosthetic repair of cardiac valves with full-flow prostheses 'MedEng-ST' in mitral and aortic positions. There were no prosthesis-associated or procedural complications during follow up. Neither were there major complications in the postoperative period. All complications were related to peculiarities of the approach to the heart. We assessed the functional parameters of the heart by standard echocardiography. The obtained findings demonstrated good haemodynamic parameters on the 'MedEng-ST' prostheses, improved intracardiac haemodynamics, which eventually had a beneficial effect on the patients' clinical picture. The transprosthetic gradients had stable parameters with a decrease in time when placing the 'MedEng-ST' prosthesis into the aortic position (p≤0.05). Proceeding from the obtained results, as well as taking into account the absence of thromboembolic events it may be stated that the proposed design of the device is universal for replacement of the aortic and mitral valves of the heart. Based on the obtained findings of the study we recommend to use the 'MedEng'ST' prostheses in clinical practice. Further studies are required for more convincing data and explicit recommendations.
No takes yet. Share an insight, caveat, or question.
Абдульянов et al. (2020) conducted a cohort in Cardiac valve disease requiring prosthetic repair (n=84). 'MedEng-ST' bicuspid full-flow mechanical prosthesis was evaluated on Prosthesis-associated or procedural complications. Use of the 'MedEng-ST' bicuspid full-flow mechanical prosthesis in 84 patients resulted in 0% prosthesis-associated complications and decreased transprosthetic gradients in the aortic position (p≤0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: